Elevance Health Inc (ELV) Shares Up 2.57% on Mar 31

robot
Abstract generation in progress

Elevance Health Inc (ELV) shares rose by 2.57% on March 31, reaching an intraday high of $295.17 before closing at $292.12. This places the stock significantly below its 52-week high but above its 52-week low. Wall Street analysts predict an average target price of $385.02 for ELV, suggesting a potential upside of 31.80%, while GuruFocus estimates a one-year GF Value of $571.80, implying a 95.74% upside.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments